Details of the Drug
General Information of Drug (ID: DMT21UX)
Drug Name |
2-Pyridin-3-yl-benzo[h]chromen-4-one
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
MLS000757116; CHEMBL177938; 1939-53-3; 2-(pyridin-3-yl)-4H-benzo[h]chromen-4-one; NSC283845; 2-pyridin-3-ylbenzo[h]chromen-4-one; 2-Pyridin-3-yl-benzo[h]chromen-4-one; AC1L88Q3; CTK0E1147; DTXSID00314472; ZINC13143019; BDBM50159611; NSC-283845; SMR000449783; TX-011635; 4H-Naphtho[1,2-b]pyran-4-one, 2-(3-pyridinyl)-
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 273.3 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 3.4 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References